Funding for this research was provided by:
Ministry of Health, Labour and Welfare (H29-Nanchitou (Nan)-Ippan-033, H29-Nanchitou (Nan)-Ippan-009)
Ministry of Education, Culture, Sports, Science and Technology (NEXT KAKENHI 25117001, NEXT KAKENHI 25117012)
Text and Data Mining valid from 2018-08-13
Received: 6 December 2017
Accepted: 11 July 2018
First Online: 13 August 2018
: All animal experiments were carried out according to the guidelines for the proper conduct of animal experiments published by the Science Council of Japan, and ethical approval for the study was granted by the Animal Care and Use Committee of Kyushu University (#No. A29-179). The Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for animal research were followed.
: Not applicable
: RY has received research support from Bayer Schering Pharma, Biogen Japan, Novartis Pharma, and Mitsubishi Tanabe Pharma. JK is a consultant for Biogen Japan and has received honoraria from Bayer Healthcare, Mitsubishi Tanabe Pharma, Nobelpharma, and Otsuka Pharmaceutical. The other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.